Schedule 13D ownership disclosure
SAB BIOTHERAPEUTICS INC
Security class unavailable · CUSIP: 78397T103
Event date: 2022-06-07
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 8,613,242
- Percent of class
- 20.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-22-018253
- Form type
- SC 13D
- Filer
- HAMILTON CHRISTINE E
- CIK
- CIK 1216114
- Filed
- Sep 08, 2022
- Reporting period
- Jun 07, 2022
- Description
- Schedule 13D beneficial ownership